Lord, Abbett & Co’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q3
Sell
-391,277
Closed -$6.02M 1067
2014
Q2
$6.02M Sell
391,277
-39,924
-9% -$614K 0.01% 765
2014
Q1
$7.35M Sell
431,201
-411,267
-49% -$7.01M 0.02% 725
2013
Q4
$10.9M Sell
842,468
-51,302
-6% -$664K 0.02% 648
2013
Q3
$9.03M Buy
893,770
+252,537
+39% +$2.55M 0.02% 667
2013
Q2
$4.79M Buy
+641,233
New +$4.79M 0.01% 814